Justera Health Ltd.
VTAL
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 320.50K | 345.00K | 371.80K | 341.80K | 353.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 320.50K | 345.00K | 371.80K | 341.80K | 353.00K |
| Cost of Revenue | 150.00K | 110.20K | 135.60K | 94.80K | 97.50K |
| Gross Profit | 170.50K | 234.80K | 236.10K | 247.10K | 255.40K |
| SG&A Expenses | 1.40M | 257.60K | 402.30K | 985.20K | 924.60K |
| Depreciation & Amortization | 25.30K | 27.90K | 28.00K | 5.30K | 98.50K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.57M | 395.70K | 565.90K | 1.09M | 1.12M |
| Operating Income | -1.25M | -50.70K | -194.10K | -743.40K | -767.70K |
| Income Before Tax | -2.60M | -22.40K | -91.00K | -102.40K | -815.20K |
| Income Tax Expenses | -- | -- | -- | -29.40K | -- |
| Earnings from Continuing Operations | -2.60M | -22.40K | -91.00K | -73.00K | -815.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.60M | -22.40K | -91.00K | -73.00K | -815.20K |
| EBIT | -1.25M | -50.70K | -194.10K | -743.40K | -767.70K |
| EBITDA | -1.23M | -31.40K | -174.60K | -736.10K | -669.20K |
| EPS Basic | -0.02 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.02 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 160.81M | 160.81M | 160.81M | 153.92M | 121.73M |
| Average Diluted Shares Outstanding | 160.81M | 160.81M | 160.81M | 153.92M | 121.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
